Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Brossart

Showing results (31-40 of 266) with videos related to

Pageof 27
Sort By:
Journal of Biomedicine & Biotechnology|July 14, 2010
RNA vaccines in cancer treatmentAnita Bringmann, Stefanie Andrea Erika Held, Annkristin Heine, et al.
Molecular Cancer|February 26, 2021
G-quadruplexes: a promising target for cancer therapyNils Kosiol, Stefan Juranek, Peter Brossart, et al.
Journal of Oncology|April 6, 2019
EF24 Suppresses Cholangiocellular Carcinoma Progression, Inhibits STAT3 Phosphorylation, and Induces Apoptosis via ROS-Mediated Oxidative StressSavita Bisht, Jens Nolting, Jörg Wenzel, et al.
Scientific Reports|July 5, 2017
Dexamethasone induced inhibition of Dectin-1 activation of antigen presenting cells is mediated via STAT-3 and NF-κB signaling pathwaysPhilipp Kotthoff, Annkristin Heine, Stefanie Andrea Erika Held, et al.
Critical Reviews in Immunology|March 8, 2007
The proteasome and its inhibitors in immune regulation and immune disordersAlessio Nencioni, Frank Grunebach, Franco Patrone, et al.
Cancer Immunology, Immunotherapy : CII|February 28, 2008
Generation of antigen-specific CTL responses using RGS1 mRNA transfected dendritic cellsFrank Grünebach, Stefanie Erndt, Maik Häntschel, et al.
Expert Opinion on Pharmacotherapy|August 10, 2012
Everolimus for the treatment of pancreatic neuroendocrine tumorsGeorg Feldmann, Savita Bisht, Ute Schütte, et al.
Cancer Immunology, Immunotherapy : CII|July 12, 2020
Selective BET-bromodomain inhibition by JQ1 suppresses dendritic cell maturation and antigen-specific T-cell responsesNiklas Remke, Savita Bisht, Sebastian Oberbeck, et al.
Case Reports in Oncology|May 21, 2013
Mixed response to ipilimumab in a melanoma patient with brain metastases: case report and review of the literatureGeorg Feldmann, Peter Brossart, Matthias Zipfel, et al.
Expert Review of Hematology|March 11, 2026
Longer time to response in hemato-oncological patients with immune thrombocytopenia (ITP): a pilot studyTessa Hattenhauer, Rebekka Mispelbaum, Peter Brossart, et al.
Pageof 27

Showing results (31-40 of 266) with videos related to

Sort By:
Pageof 27
Journal of Biomedicine & Biotechnology|July 14, 2010
RNA vaccines in cancer treatmentAnita Bringmann, Stefanie Andrea Erika Held, Annkristin Heine, et al.
Molecular Cancer|February 26, 2021
G-quadruplexes: a promising target for cancer therapyNils Kosiol, Stefan Juranek, Peter Brossart, et al.
Journal of Oncology|April 6, 2019
EF24 Suppresses Cholangiocellular Carcinoma Progression, Inhibits STAT3 Phosphorylation, and Induces Apoptosis via ROS-Mediated Oxidative StressSavita Bisht, Jens Nolting, Jörg Wenzel, et al.
Scientific Reports|July 5, 2017
Dexamethasone induced inhibition of Dectin-1 activation of antigen presenting cells is mediated via STAT-3 and NF-κB signaling pathwaysPhilipp Kotthoff, Annkristin Heine, Stefanie Andrea Erika Held, et al.
Critical Reviews in Immunology|March 8, 2007
The proteasome and its inhibitors in immune regulation and immune disordersAlessio Nencioni, Frank Grunebach, Franco Patrone, et al.
Cancer Immunology, Immunotherapy : CII|February 28, 2008
Generation of antigen-specific CTL responses using RGS1 mRNA transfected dendritic cellsFrank Grünebach, Stefanie Erndt, Maik Häntschel, et al.
Expert Opinion on Pharmacotherapy|August 10, 2012
Everolimus for the treatment of pancreatic neuroendocrine tumorsGeorg Feldmann, Savita Bisht, Ute Schütte, et al.
Cancer Immunology, Immunotherapy : CII|July 12, 2020
Selective BET-bromodomain inhibition by JQ1 suppresses dendritic cell maturation and antigen-specific T-cell responsesNiklas Remke, Savita Bisht, Sebastian Oberbeck, et al.
Case Reports in Oncology|May 21, 2013
Mixed response to ipilimumab in a melanoma patient with brain metastases: case report and review of the literatureGeorg Feldmann, Peter Brossart, Matthias Zipfel, et al.
Expert Review of Hematology|March 11, 2026
Longer time to response in hemato-oncological patients with immune thrombocytopenia (ITP): a pilot studyTessa Hattenhauer, Rebekka Mispelbaum, Peter Brossart, et al.
Pageof 27